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Despite a large body of evidence concerning the phenomenon of immune
tolerance at the T cell level, the actual mechanism of unresponsiveness is not
understood. Experimentally, T cell unresponsiveness can be induced in adults
by the intravenous injection of high doses of soluble antigen (1) or of antigen
coupled to syngeneic splenocytes (reviewed in references 2-6). Two major
hypotheses have been proposed (3-6) to explain unresponsiveness: regulation by
suppressor T cells or direct inactivation ofresponding T cells by antigen.
The suppression model of unresponsiveness states that a complex circuit of
interacting suppressor T cells prevent the expression ofinducer T cell function.
The antigen and MHC specificity ofsuppression has been shown in most systems
to be different from that of inducer T cells, e. g., inducer T cells recognize
antigen in association with class 11 MHC (Ia) molecules, while suppressor T cells
often recognize antigen in an unrestricted fashion, or in association with 1-J
molecules (2, 7, 8). However, several instances of la-restricted antigen recogni-
tion by suppressor T cells have been described (9, 10). As an alternative to
suppression, models ofdirect T cell inactivation (clonal deletion) state that under
certain conditions inducer T cells of the appropriate specificity are functionally
or physically deleted after interaction with antigen and la molecules (3-6).
Attempts to distinguish between suppression and clonal deletion models have
been greatly hampered by the lack of in vitro model systems with which to study
the inductive events leading to unresponsiveness. Lamb and coworkers (11) have
reported that class I1-restricted human T cell clones could be rendered unre-
sponsive in vitro after incubation with free antigen. Although this result sug-
gested that tolerance induction and T cell activation had different specificities,
subsequent studies by these investigators (12) showed that unresponsiveness
induced in vitro could be blocked by anti-class 11 antibodies. The relationship
of these in vitro observations to the in vivo phenomenon of T cell tolerance
induction remained unclear,
To address these issues, we examined the specificity of tolerance induction
both in vivo and in vitro using the well-defined response ofB10.A mice to pigeon
cytochrome c asa modelsystem. Previous studies (13) have shown thatsplenocytes
coupled with peptide antigens via the chemical crosslinker I-ethyl-3-(3-dimethyl-
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aminopropyl) carbodiimide (ECDI)' are tolerogenic in vivo. Our results show
that when ECDI-treated splenocytes were used in vitro as APCs, they failed to
stimulate proliferation by pigeon cytochrome c-specific normal T cell clones and
instead induced a state oflong-term unresponsiveness that could not be attributed
to suppressor T cells. The induction of T cell unresponsiveness in vitro had the
same antigen and la molecule specificity as T cell activation. Furthermore, as
predicted by the in vitro results, T cell unresponsiveness was induced in vivo by
the intravenous injection of antigen-coupled splenocytes prepared by ECDI
treatment. The induction of this in vivo unresponsiveness also had the same
antigen and la molecule specificity as T cell activation. The experiments sug-
gested that ECDI treatment alone inactivated an APC function, converting the
splenocytes to cells that displayed antigen and la molecules, but that induced T
cell tolerance instead of proliferation. These results are most consistent with a
functional clonal deletion model of T cell tolerance induction and suggest that
antigen/la molecule recognition under nonmitogenic conditions can result in
induction of an unresponsive state.
Materials and Methods
Mice.
￿
B10 .A/SgSn mice were purchased from The Jackson Laboratory, Bar Harbor,
ME. B10 .A(4R)/SgSn, B10 .A(2R)/SgSn, B10 .A(3R), B10 .A(5R), B10 .A(18R), and
C57BL/IOSn (1110) mice were bred in our own colony from Caesarian-derived litters of
breeding pairs obtained from Dr. Jack Stimpfling, McLaughlin Research Laboratory,
Great Falls, MT. Mice were sex matched within experiments and used between 2-12 mo
of age.
Antigens.
￿
Pigeon cytochrome c was purchased from Sigma Chemical Co., St. Louis,
MO . Duck cytochrome c, prepared as described (14), was the kind gift of Dr. E. Margoliash,
Northwestern University, Evanston, IL. Pigeon cytochrome c fragments 1-65, 66-80, and
81-104 were prepared by cyanogen bromide cleavage and were purified on a Sephadex
G50 superfine column (Pharmacia Fine Chemicals, Piscataway, NJ) (15). An analog of
moth cytochrome c fragment 93-103 containing a glutamine for lysine substitution at
position 99 and a glutamic acid for aspartic acid substitution at position 93, moth 93-
103(93E,99Q), was synthesized by Dr. Barbara Fox (National Institute of Allergy and
Infectious Diseases, Bethesda, MD) using the Merrifield solid-phase procedure as previ-
ously described (16). Another analog of moth cytochrome c containing a glutamic acid
for aspartic acid substitution at position 93 and an alanine for leucine substitution at
position 98, moth 86-89;93-103(93E,98A)2 was prepared by the Merrifield solid-phase
procedure and was kindly provided by Dr. B. Singh (Dept. of Immunology, University of
Alberta, Canada) . PPD was purchased from Connaught Laboratories Ltd., Willowsdale,
Ontario, Canada. GAT was purchased from Vega Biotechnologies, Inc., Tucson, AZ.
Preparation ofECDI-treated Splenocytes.
￿
Erythrocyte-free splenocytes were treated with
ECDI as previously described (13). Briefly, 108 spleen cells were incubated for 1 h on ice
in 0.44 ml of 0.9% NaCl containing 75 mM ECDI (Calbiochem-Behring Corp., La Jolla,
CA) . The cells were washed extensively in serum-free RPMI 1640 medium to stop the
coupling reaction. In some experiments, splenocytes were fractionated into T cell-
enriched or B cell and macrophage-enriched populations before ECDI treatment. T cell-
enriched populations were obtained by treating nylon-wool nonadherent (17) B10.A
splenocytes with 14.4.45 (anti-E'#:E',, reference 18) and 10 .2.16 (anti-As:A',; reference 19)
mAbs (1 :1000 ascites) for 1 h on ice, followed by a 30-min incubation in a 1 :4 dilution of
guinea pig complement (Gibco Laboratories, Grand Island, NY) at 37°C. These cells
' Abbreviation used in this paper:
￿
ECDI, 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide.
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responded well to Con A in the presence of irradiated splenocytes but failed to respond
to LPS (data not shown). B cell plus macrophage-enriched populations were obtained by
treating BIO.A splenocytes with 31 .11 (anti-Thy-1, reference 20), 53-7.3 (anti-Ly-1,
reference 21), 53-6.7 (anti-Lyt-2, reference 21), and MAR 18.5 (mouse anti-rat Ig,
reference 22) mAbs (1 :10 culture supernatants) plus complement. These cells failed to
respond to Con A but responded well to LPS (data not shown). For the in vivo experiments,
peptide antigens were directly coupled to BIO.A, BI O.A(3R), BIO.A(5R), BIO.A(18R), or
BI O.A(4R) splenocytes as described above except that the reaction mixture contained 400
,M antigen and 75 mM ECDI. Where indicated, BIO.A splenocytes were depleted of cells
bearing la molecules as described above for preparation of T cell-enriched populations,
just before antigen coupling. Trace labeling studies indicated that 0.5 ug of pigeon
cytochrome c was coupled to 10' splenocytes (data not shown).
T Cell Clones.
￿
Normal T cell clones A.E7 (23) and F1 .A.2 (24) were derived from
pigeon cytochrome c-immunized BIO.A and (B10 .A(3R) X B10.A)F, mice, respectively.
Normal T cell clone 3R.3 .11 (25) was derived from BIO.A(3R) mice immunized with
pigeon cytochrome c fragment 1-65 . All three normal clones express the L3T4+, Lyt-2-
surface phenotype. T cell clones were routinely maintained by a modification of the
Kimoto and Fathman (26) rest-stimulation protocol as described by Ashwell et al. (27).
For the in vitro tolerance experiments, T cell clones were maintained by weekly addition
of only IL-2-containing supernatants (25-50 U/ml) for 1 mo after the last stimulation
with antigen and irradiated splenocytes (3,000 rad). The few surviving splenocytes were
then depleted by anti-la molecule plus complement treatment: 10.2.16 and 14.4.4S for
A.E7 and F1 .A.2, or M5/114 (anti-As:A',, reference 28) for 3R.3 .11 . Dead cells were
removed on Ficoll-Hypaque density gradients (Pharmacia Fine Chemicals). After this
treatment, T cell clones failed to respond to high doses of antigen plus allogeneic
splenocytes, indicating complete depletion of syngeneic APC.
T Cell Clone Proliferation Assay.
￿
Cloned T cells (2 X 10') were cultured in 0.2 ml of
Click's medium supplemented with 10% heat-inactivated FCS, 2 X 10-6 M glutamine, 5
X 10-5 M 2-ME, and antibiotics in 96-well microtiter plates (Costar No. 3596; Costar,
Cambridge, MA) with 5 X 105 irradiated (3,000 rad) syngeneic splenocytes and varying
doses of antigen or with IL-2 alone (100 U/ml). Where indicated, cultures contained 5 X
105 ECDI-treated splenocytes as APC. After 2 d of culture, 1 uCi of [sH]thymidine (6.7
mCi/mM, New England Nuclear, Boston, MA) was added to each well . 16 h later, the
cells were harvested using a PHD cell harvester (Cambridge Technology, Inc., Cambridge,
MA). Thymidine incorporation into DNA was quantitated by liquid scintillation counting.
Determinations were performed in duplicate with the results expressed as A cpm, i .e.,
(mean cpm in antigen stimulated wells) - (mean cpm in wells without antigen). Background
proliferation (no antigen) was routinely <1,000 cpm.
Induction of T Cell Clone Unresponsiveness In Vitro.
￿
T cell clones (5 X 105) were
preincubated overnight in Costar 24-well plates (No. 3524) in 2.0 ml of medium containing
5 X 106 ECDI-treated splenocytes with or without soluble antigen. In some experiments,
purified 14.4.4S or 10.2 .16 mAbs (I wg/ml, kindly provided by Dr. A. Kruisbeek, NIH)
were added to the preincubation cultures. The cloned T cells were recovered the next
day on Ficoll-Hypaque density gradients, washed extensively in RPMI 1640, and restim-
ulated (2 X 10') with fresh, irradiated splenocytes (5 X 105) and antigen in 96-well
microtiter plates, as described above for the T cell clone proliferation assay. Recovery
from preincubation cultures was routinely 60-80% ofthe input cell number. T cell clones
preincubated in the absence of antigen with ECDI-treated or normal splenocytes re-
sponded similarly to restimulation, suggesting that the ECDI-treated cells were not toxic
(data not shown).
Kinetics and Duration of T Cell Clone Unresponsiveness Induced In Vitro. For the
experiments shown in Fig. 6, A.E7 cells (5 X 105) were incubated with 5 X 106 ECDI-
treated BIO.A splenocytes in 2 .0 ml medium with or without 5 UM pigeon fragment 81-
104 for 2, 5, or 16 h. At the indicated times, A.E7 cells were separated from the treated
APC and antigen on density gradients, washed extensively, and restimulated with normal
APC and antigen as described above. For the experiments shown in Fig. 7, F1 .A.2 cellsJENKINS AND SCHWARTZ
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ECDI-treated splenocytes fail to stimulate proliferation by a normal T cell clone.
5 x 105 ECDI-treated (open circles) or 3,000 rad irradiated normal (filled circles) B10.A
splenocytes were cultured with 2 X 104 F1 .A.2 normal cloned T cells and the indicated doses
of pigeon fragment 81-104. Proliferation by F1 .A.2 was determined by ['Hlthymidine incor-
poration with the results expressed as 0 cpm.
(5 X 10) were incubated overnight with 5 X 106 ECDI-treated B10.A splenocytes in 2 .0
ml medium with or without 1 gM pigeon fragment 81-104. The T cells were recovered,
washed, and 2 X 104 cell were placed in 0.1 ml medium in 96-well microtiter plates. At
later times, 5 X 105 irradiated B10.A splenocytes and various doses of pigeon fragment
81-104 or IL-2 alone were added in 0.1 ml of medium. Restimulation with normal APC
and antigen was determined as described above.
Induction of T Cell Unresponsiveness In Vivo.
￿
Mice were injected intravenously with 0 .5
ml RPM1 1640 containing either 2 X 10' or 5 X 10' antigen- or sham-coupled splenocytes.
1 or 4 days after injection, recipient mice were immunized subcutaneously in each footpad
and at the base of the tail with a total of 10 nmol (in 0 .2 ml) of pigeon cytochrome c or
moth 86-89;93-103(93E,98A) emulsified in CFA containing Mycobacterium tuberculosis
H37Ra (Difco Laboratories Inc., Detroit, MI).
Lymph Node TCell Proliferation Assay.
￿
7 d after priming, draining lymph node T cells
were prepared by passage over nylon-wool columns (17). T cells (4 X 105 cells/well) were
cultured in 96-well microtiter plates with varying doses of pigeon cytochrome c fragment
81-104, moth 86-89; 93-103(93E,98A), or PPD, and 105 irradiated (3,000 rad) syngeneic
spleen cells in 0.2 ml of medium. Cultures were pulsed with ['Hlthymidine on day 3,
harvested on day 4, and thymidine incorporation was determined as described above.
Determinations were performed in triplicate and the results are expressed as A cpm ±
SEM calculated as the square root of the sum of the squares of the individual errors.
Results
Antigen Presentation by ECDI-treated Splenocytes to T Cell Clones In Vitro.
Previous analyses (13) have revealed that specific T cell unresponsiveness can
be induced in vivo by the intravenous injection of syngeneic splenocytes coupled
with protein antigens by the chemical crosslinker ECDI. To gain a better
understanding of this unresponsiveness, we examined the antigen presentation
capacity of ECDI-treated splenocytes in vitro. Normal B10.A T cell clones
proliferate in response to the COOH-terminal cyanogen bromide fragment of
pigeon cytochrome c (residues 81-104) in association with the E#:Ea la molecule
expressed on APC (29). However, a clone with this specificity (F1 .A.2) failed to
proliferate in response to B10 .A splenocytes coupled with pigeon fragment 81-
104 by ECDI (data not shown), or to ECDI-treated B10.A splenocytes and
soluble pigeon fragment 81-104 (Fig. 1). In contrast, normal B10.A splenocytes
and pigeon fragment 81-104 stimulated a vigorous proliferative response.
Several observations suggested that the inability of ECDI-treated APC to306
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FIGURE 2.
￿
Induction of T cell unresponsiveness in vitro. Cloned T cell A.E7 (5 X 105) was
incubated overnight with various ECDI-treated BI O.A spleen cell populations with or without
pigeon fragment 81-104. T cell-enriched and B cell plus macrophage-enriched populations
were prepared as described in Materials andMethods. The A.E7 cellswere reisolated the next
day and cultured (2 X 10") with the indicated antigen doses and 5 X 105 irradiated BIO.A
spleen cells or IL-2-containing supernatants (100 U/ml) alone. Proliferation of restimulated
cells was measured by ['H)thymidine incorporation and the results are expressed as 0 cpm.
A.E7 preincubation conditions: ECDI-treated B10.A unfractionated splenocytes with (open
circles) or without (filled circles) 5 juM pigeon fragment 81-104, or ECDI-treated B10.A T
cells plus 5 ~uM pigeon fragment 81-104 (open triangles) or ECDI-treated BIO.A B cells and
macrophages plus 5 juM fragment 81-104 (open squares).
stimulate proliferation was probably not the result of extensive la molecule
modification. First, ECDI-treated splenocytes had la-restricted effects on normal
T cell clones that could be blocked with anti-la mAbs (see below). Second, ECDI-
treated APC expressed relatively normal levels of la molecules, as detected by
mAbs (data not shown). Finally, ECDI-treated APC could weakly stimulate IL-2
production by the 2134 T cell hybridoma (data not shown) ; this cell requires only
pigeon fragment 81-104 and Efl:E', molecules for activation, as demonstrated by
studies using purified la molecules incorporated into planar membranes (29a).
These observations are most consistent with the interpretation that ECDI treat-
ment inactivated an accessory function of the APC that is necessary to stimulate
proliferation by a normal T cell clone.
The Induction of T Cell Unresponsiveness In Vitro.
￿
The observation that ECDI-
treated APC expressed functional la molecules and yet failed to stimulatenormal
T cell clones to proliferate raised the possibility that recognition of antigen on
ECDI-treated APC resulted in unresponsiveness. To test this, the normal T cell
clone A.E7 (specific for pigeon fragment 81-104 and Ek:Eb) was preincubated
overnight with various ECDI-treated B10.A spleen cell populations, with or
without antigen, and then was restimulated with antigen and untreatedsyngeneic
APC (Fig. 2). A.E7 cells preincubated with pigeon fragment 81-104 and either
ECDI-treated B10.A unfractionated splenocytes or ECDI-treated B10.A B cells
plus macrophages were almost completely unresponsive to restimulation with
untreated B10.A splenocytes andpigeon fragment 81-104 . These cells responded
well to exogenous IL-2, indicating that cell death did not account for antigen/la
molecule unresponsiveness. In contrast, A.E7 cells preincubated with ECDI-
treated BlO.A splenocytes in the absence of antigen or with ECDI-treated BlO.A
T cells plus pigeon fragment 81-104 responded well to restimulation with
untreated APC and antigen. These results demonstrated that antigen presenta-
tion in vitro by ECDI-treated splenocytes results in T cell unresponsiveness. In100,000
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FIGURE 3.
￿
MHCspecificity o£ T cell unresponsiveness induced in vitro. Cloned T cells (5 X
105)A.E7 (a) or 3R.3 .11 (b) were incubated overnight with 5 X 106 ECDI-treated splenocytes
with or withoutantigen. TheTcellswere reisolated andrecultured (2 X 104)with theindicated
antigens, and 5 X 105 B10.A (for A.E7) or B10 (for 3R.3.11) irradiated spleen cells or IL-2-
containing supernatants (100 U/ml)alone. Proliferation ofrestimulated cellswasmeasured by
[sH]thymidine incorporation. A.E7 preincubation conditions: ECDI-treated B10.A splenocytes
with (open circles) or without (filled circles) 0.5 uM pigeon fragment 81-104, or ECDI-treated
B10 splenocytes with (open squares) or without pigeon fragment 81-104 (filled squares). (b)
3R.3.11 preincubation conditions: ECDI-treated B10 splenocytes with (open squares) or with-
out pigeon fragment 1-65 (filled squares), or ECDI-treated B10.A splenocytes with (open
circles) or without pigeon fragment 1-65 (filled circles).
307
addition, the critical population in spleen responsible for the induction of
unresponsiveness was ECDI-treated la' cells (B cells plus macrophages) and not
ECDI-treated T cells, strongly arguing against a role for suppressor T cells in
this phenomenon.
Specificity of the Induction of T Cell Unresponsiveness In Vitro.
￿
It has been
demonstrated (8, 29) that inducer T cell activation requires recognition of
antigen in association with MHC molecules. The experiments shown in Fig. 3
were performed to determine if a similar restriction governed the induction of
T cell unresponsiveness in vitro. A.E7 cells (specific for fragment 81-104 and
E'3:E' .) preincubated with ECDI-treated B10.A splenocytes and pigeon fragment
81-104 were almost completely unresponsive to restimulation with normal B10.A
splenocytes and pigeon fragment 81-104 (Fig. 3a). Unresponsiveness was not
induced after preincubation with ECDI-treated BIO.A splenocytes alone or with
ECDI-treated B10 splenocytes bearing A#:A, class lI molecules with or without
pigeon fragment 81-104. In the reciprocal experiment, clone 3R.3.11 (specific
forpigeon fragment 1-65 and A'O:A' .) wasrendered unresponsive to restimulation
with B10 splenocytes and pigeon fragment 1-65 by preincubation with ECDI-
treated B10 splenocytes and fragment 1-65, but not ECDI-treated B10 spleno-
cytes alone or ECDI-treated BIO.A splenocytes with or without antigen (Fig.
3b). Both A.E7 and 3R.3.11 cells that were rendered unresponsive to antigen
and la molecule restimulation responded to exogenous IL-2, demonstrating that
cell death did not account for unresponsiveness. These results show that the
induction of T cell unresponsiveness in vitro is MHC-restricted.
The specificity of unresponsiveness induced in vitro was further examined as
shown in Fig. 4. FLA.2 cells were rendered unresponsive to restimulation with
B10.A APC and pigeon fragment 81-104 after preincubation with ECDI-treated
B10.A splenocytes and pigeon fragment 81-104, but not with moth 93-30 8
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FIGURE 4.
￿
Antigen and la molecule specificity of T cell unresponsiveness induced in vitro.
Tcell clone FI.A.2 was preincubated with ECDI-treated splenocytes with or without antigen
as described in the legend to Fig. 2. Proliferation of restimulated cells was measured by [sH]-
thymidine incorporation. F1 .A.2 preincubation conditions: ECDI-treated B10.A splenocytes
with (open circles) or without (filled circles) 1.0 jAM pigeon fragment 81-104 (a and b), or
ECDI-treated B10.A splenocytes with 1.0 AM moth peptide 93-103(93E,99Q)(a, open trian-
gles), or ECDI-treated BIO.A(4R) splenocytes with (b, open squares) or without(b,filled squares)
1.0 ,iiM pigeon fragment 81-104.
103(93E,99Q), a nonstimulatory peptide analog containing the moth cytochrome
c sequence with a glutamine for lysine substitution at residue 99 (29) (Fig. 4a).
Similarly, preincubation of FI .A .2 with pigeon fragment 81-104 and ECDI-
treated B10.A(4R) splenocytes, which do not express E, 3:E, molecules, did not
result in unresponsiveness (Fig. 4b). Furthermore, preincubation of A.E7 with
ECDI-treated BIO.A splenocytes and pigeon fragment 81-104, in the presence
of anti-E,:E. but not anti-A#:A« mAbs, completely blocked the induction of
unresponsiveness in vitro (Table I), demonstrating that the la molecules present
on ECDI-treated splenocytes are required for the induction of the unresponsive
state. In all cases, unresponsiveness could not be accounted for by cell death, as
the clones proliferated well in response to exogenous IL-2 after preincubation
with the appropriate antigen and ECDI-treated APC. These results demonstrate
that the induction of T cell unresponsiveness in vitro has the identical antigen
and la molecule specificity as the induction of the T cell clone's proliferative
response.
Dependence of the Induction of Unresponsiveness on the Antigen Concentration and
the Number of ECDI-Treated APC. The quantitative aspects of the induction of
unresponsiveness are shown in Fig. 5. A.E7 preincubated with a fixed number
of ECDI-treated B10.A splenocytes and increasing concentrations of pigeon
fragment 81-104 (Fig. 5a), or with a fixed concentration of pigeon fragment 81-
104 and increasing numbers of ECDI-treated BIO.A splenocytes (Fig. 5b), were
progressively less responsive to restimulation. Maximal effects were observed
with 1-10 AM of antigen and 5 x 106 ECDI-treated splenocytes.
Kinetics of Induction of T Cell Unresponsiveness In Vitro.
￿
A.E7 cells wereJENKINS AND SCHWARTZ
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TABLE I
Effect ofAnti-la mAbs on the Induction ofTCell Unresponsiveness In Vitro
*A.E7 cells (5 X 10 5) were preincubated overnight with 5 X 106 ECDI-treated BIO.A splenocytes
without antigen (group A) or with 5 X 106 ECDI-treated BIO.A splenocytes and 5 JAM pigeon
fragment 81-104 without (group B) or with 1 jug/ml 14.4.4$ (group C) or 10.2.16 (group D)mAbs.
*After preincubation, A.E7 cells were reisolated and cultured (2 X 10') with 5 X 10 5 B10.A
irradiated splenocytes with or without 0.01 uM pigeon fragment 81-104 or 100 U of IL-2 alone .
The results are expressed as A cpm .
§ Numbers in parentheses show percent inhibition ofthe proliferative response compared with group
A.
FIGURE 5 .
￿
Dose dependency ofT cell unresponsiveness on antigen concentrationand APC
number. T cell cloneA.E7 (5 X 10 5) was preincubated overnight with 5 X 106 ECDI-treated
BIO.A splenocytes and the indicated concentrations (AM) of pigeon fragment 81-104 (a) or
with 1 uM pigeon fragment 81-104 and the indicated numbers of ECDI-treated B10 .A
splenocytes (b) . TheT cells were reisolated and restimulated as described in the legend to Fig .
2 . The results are expressed as Acpm .
preincubated with ECDI-treated BlO.A splenocytes with or without pigeon
fragment 81-104 for various periods of time to determine the time course for
the induction of unresponsiveness in vitro (Fig . 6) . Unresponsiveness to re-
stimulation with normal APC and antigen was apparent after only 2 h, was
partially induced after 5 h, and was completely induced after 16 h of preincu-
bation . Thus, unresponsiveness wasnot totallyinduced immediately, but required
>5 h to achieve a maximal effect .
Duration ofT Cell Unresponsiveness Induced In Vitro .
￿
The duration of in vitro-
induced unresponsiveness was tested by preincubating FLA.2 cells overnight
with ECDI-treated BIO.A splenocytes with or without pigeon fragment 81-104,
followed by restimulation 2, 4, 6, or 8 d later (Fig . 7) . At all time points, FLA.2
cells were completely unresponsive to restimulation with untreated BIO.A sple-
nocytes and antigen, although they remained responsive to IL-2 (datanotshown) .
Thus, as reported for unresponsiveness induced in vivo by antigen-coupled cells
Preincubation conditions* Restimulation response
(A cpm) to :
Group
T cell APC Antigen Antibody BIO.A APC+ IL-2 clone 81-104
A A.E7 B10.A-ECDI - - 95,000 110,000
B A.E7 B10.A-ECDI 81-104 - 2,500 (97)¢ 125,000
C A.E7 B10.A-ECDI 81-104 14.4.4$ (anti-Ep:E .) 87,500(8) 105,000
D A.E7 B10.A-ECDI 81-104 10.2.16 (anti-AB:Aa) 3,000 (97) 155,00031 0
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FIGURE 6.
￿
Time course of the induction of T cell unresponsiveness in vitro. T cell clone
A.E7 (5 x 10 5) was preincubated with 5 x 10 6 ECDI-treated BIO.A splenocytes with (open
circles) or without (filled circles) 5 AM pigeon fragment 81-104 for the indicated times, after
which the T cells were reisolated and restimulated as described in the legend to Fig. 2. The
resultsare expressed as 0 cpm.
(30), unresponsiveness induced in vitroappears to last for a relatively long period
of time.
Specificity of T Cell Unresponsiveness Induced In Vivo.
￿
Our studies demonstrate
that ECDI-treated splenocytes induce T cell unresponsiveness in vitro. In addi-
tion, others have shown (3-5, 13) that intravenous injection of antigen-coupled
splenocytes results in T cell unresponsiveness in vivo. Based on these observa-
tions, we examined the fine specificity of T cell unresponsiveness to pigeon
cytochrome c induced in vivo. B10.A mice were injected intravenously with
BIO.A splenocytes coupled with antigen via ECDI. 4 d later, recipient mice were
immunized in the footpads with pigeon cytochrome c emulsified in CFA. As
shown in Fig. 8, T cells from recipients of splenocytes coupled via ECDI with
intact pigeon cytochrome c or pigeon fragment 81-104 proliferated very poorly
in response to fragment 81-104 (Fig. 8a), although these cells responded nor-
mally to PPD present in the adjuvant used for immunization (Fig. 8c). Control
T cells from mice receiving splenocytes treated with ECDI in the absence of
antigen, proliferated strongly in response to pigeon fragment 81-104 (Fig. 8a).
The intact molecule was a better tolerogen than the 81-104 fragment, possibly
because there also exist B10.A T cells that are specific for pigeon fragment 1-65
in association with A'6:Aa (25); these may have facilitated the survival and/or
expansion of T cells specific for fragment 81-104 and E13:Ea.JENKINS AND SCHWARTZ
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FIGURE 7.
￿
Duration of T cell unresponsiveness induced in vitro. T cell clone FLA.2 (5 X
105/well) was preincubated with ECDI-treated B10.A splenocytes (5 X 106/well) with (open
circles) or without (filled circles) 1.0 pM pigeon fragment 81-104. TheT cellswere reisolated,
placed in microtiter plates (2 X 10'), and restimulated by the addition of various antigen
concentrations and 5 X 105 irradiated BIO.A splenocytes 2, 4, 6, or 8 d later. The results are
expressedas 0cpm.
The antigen specificity of the tolerance induction was similar to that of
proliferation because B10.A splenocytes coupled with pigeon fragment 66-80 or
intact duck cytochrome c (neither of which stimulate a proliferative response in
B10.Amice, reference 31) failed to induce hyporesponsiveness in vivo (Fig. 8a).
A requirement for la molecules was also demonstrated, as B10.A splenocytes
that were depleted of cells bearing la molecules and then coupled with pigeon
cytochrome c were poor tolerogens in vivo (Fig. 8b). Furthermore, pigeon 81-
104-coupled B10.A(4R) splenocytes (Kk, A#, Aa, Es, E., Db), which donot express
E, 9:E, molecules, failed to induce fragment 81-104-specific T cell unresponsive-
ness in pigeon cytochrome c-primed B10.A (Kk, As, A., E0, Ea, Dd) mice (Fig. 9,
a-c). This suggests that the Ek:Ea la molecule is necessary for the tolerance
induction. An alternative explanation for this last result, however, is that allo-
geneic effects in vivo due to the H-2D region disparity between B10.A and
B10.A(4R) obscured the tolerance induction. To eliminate this possibility the
experiment was repeated using BIO.A(2R) (K'`, A#, Aa, Efl, E., Db) recipients and
fragment 81-104, ECDI-coupled B10.A(2R) (tolerogenic) vs. B10.A(4R) (non-312
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FIGURE 8.
￿
Antigen specificity of unresponsiveness induced in vivo by ECDI-treated spleno-
cytes. B10.A mice (two per group) were injected intravenously with 2 x 107 ECDI-treated
B10.A splenocytes coupled with pigeon cytochrome c(closed squares in a-c), pigeon fragment
81-104 (open circles in a and c), pigeon fragment 66-80 (open squares in a and c), duck
cytochrome c (open triangles in a and c), nothing (filled circles in a-c), or 2 x 107 B10.A
splenocytes depleted of cellsbearing la molecules and then coupled with pigeon cytochrome
c (filled triangles in b). 4 d later, recipient mice were immunized with pigeon cytochrome c in
CFA. 7 d after priming, draining lymph node T cell proliferation in response to pigeon
fragment 81-104 (a and b) or PPD (c) was determined in a ['Hlthymidine uptake assay. The
results are expressed as 0cpm. cpm values for no antigen controls ranged from 1,779 ± 304
to 3,343 ± 637.
tolerogenic) splenocytes. The results were the same (data not shown). It should
be noted that B10.A(4R) splenocytes, ECDI-coupled with GAT, an antigen
recognized in association with AO:A' (32), induced specific unresponsiveness to
GAT in syngeneic recipients (data not shown). This control showed that antigen-
coupled B10.A(4R) splenocytes could be tolerogenic when their expressed la
molecule was involved in activation.
Finally, to rule out a role for I-J in this particular form of tolerance induction,
B10.A(3R) mice (A#, A., Es, Ea, I- )were injected intravenously with B10.A(5R)
splenocytes (A#, Aa, Efl, Ea, IJk) coupled via ECDI with a synthetic analog of
moth cytochrome c, 86-89;93-103(93E,98A). As shown in Fig. 10 this I+
incompatible combination induced the maximum level of unresponsiveness at-
tainable with the syngeneic combination. In contrast, B10.A(18R) splenocytes
(AQ, Aa, Eb6, E«, If
b
), which are IJ-compatible with B10.A(3R) but do not express
E, 3:Ea molecules, failed to induce maximal unresponsiveness. The partial unre-
sponsiveness observed in this case maybe due to the existence ofAO:A.-restricted,
86-89;93-103(93E,98A)-specific clones in BIO.A(3R) mice. Taken together,
these experiments demonstrate that the induction of T cell unresponsiveness in
vivo to pigeon cytochrome c has the same antigen and la molecule specificity
(fragment 81-104 and E,3:E,) as does the induction of T cell unresponsiveness in
vitro. We conclude from these experiments that this form of tolerance induction
is MHC-restricted.
In this report we demonstrate that antigen presentation by chemically modified
APC can induce unresponsiveness in vitro for T cell clones and in vivo for lymph
node T cells. The induction of this unresponsiveness had the same antigen and
MHC specificity as T cell activation, i. e., it depended on both the E#:E. la60,000
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FIGURE 9.
￿
Fragment 81-104, ECDI-coupled B10.A(4R) splenocytes do notinduce unrespon-
siveness in B10.A . B10.A mice (two per group) were injected intravenously with 5 X 10'
ECDI-treated BIO.A splenocytes (a) coupled with nothing (filled circles) or pigeon fragment
81-104 (open circles), or with 5 X 10' BIO.A(4R) ECDI-treated splenocytes (b) coupled with
nothing (filled squares) or fragment 81-104 (open squares). 1 d later, mice were primed with
pigeon cytochrome c and 7 d later, T cell proliferation was determined as described in the
legend to Fig. 8. The results are expressed as 0 cpm. cpm values for no antigen controls
ranged from 657 ± 117 to 1,098 ± 103. (a and b) the response to pigeon fragment 81-104 ;
(c) the response to PPD.
molecule and on residues contained within the pigeon cytochrome c fragment
81-104. Furthermore, the failure ofmoth 93-103(93E,99Q) to induce unrespon-
siveness in vitro demonstrated the requirement for recognition of the lysine at
position 99, a residue that has been suggested (29) to contact the T cell receptor
of clones specific for pigeon fragment 81-104. Our findings are consistent with
a recent report (33) that demonstrated that the specificity of the induction of
neonatal tolerance in vivo was identical to that of T cell activation and other
reports (4, 34-37) that have demonstrated that tolerance induction in vivo and
in vitro is MHC-restricted.
Previous work has shown (2, 38) that T suppressors contribute to unrespon-
siveness by inhibiting the function of helper and delayed-type hypersensitivity T
cells. Several points suggest that the in vivo unresponsiveness examined in this
paper is not mediated by suppression. T suppressors generally do not inhibit T
cell proliferation (13, 38), although some examples have been reported (39, 40).
Furthermore, in several instances proliferative T cells and T suppressors have
been shown to recognize distinct portions of the same antigen (8). Oki and
Sercarz (1) have shown that removal of a suppressor determinant destroys the314
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FIGURE 10.
￿
I,J compatibility is not required for the induction of T cell unresponsiveness in
vivo. BIO.A(3R) mice (two per group) were injected intravenously with 5 X 107 ECDI-treated
BI O.A(3R) splenocytes coupledwith nothing (filled circles) or 5 X 107ECDI-treated B10.A(3R)
(open circles), B10.A(5R) (filled squares), or B10.A(18R) (open squares) splenocytes coupled
with moth 86-89;93-103(93E,98A). I d later, mice were primed with 10 nmol of moth 86-
89;93-103(93E,98A) and 7 d later, T cell proliferation was determined in a ['H]thymidine
uptake assay. The results are expressed as 0 cpm. cpm values for no antigen controls ranged
from 524 ± 29 to 1,140 ± 735.
tolerogenicity of hen egg white lysozyme. In contrast, pigeon cytochrome c
fragment 81-104, which contains the antigenic determinant recognized by pro-
liferative T cells, induced unresponsiveness when associated with the E"k:Eak la
molecule, suggesting a direct effect of the tolerogen on the responding T cells.
However, the failure of fragment 81-104, ECDI-coupled B10.A(4R) splenocytes
(I Jb) to tolerize the pigeon cytochrome c response of BIO.A or B10.A(2R)
recipients (I Jk) could also be attributed to the requirement for I-J compatibility
between the tolerogen and suppressor T cells (2, 4). That this is not the case is
indicated by experiments in which moth cytochrome c, ECDI-coupled BIO.A(5R)
splenocytes (E,9, E., IJk) induced maximal moth cytochrome c-specific T cell
unresponsiveness in IJ-incompatible BIO.A(3R) recipients (E', Ea, IJ
b
), whereas
moth cytochrome c, ECDI-coupled IJ-compatible B10.A(18R) splenocytes (Eb b,
E,, If
b
) did not. Thus, I-E compatibility appears to be necessary and sufficient
for this form of rapid tolerance induction.
Our observation that cloned T cells could be rendered unresponsive in vitro
suggests a direct effect of antigen and ECDI-treated APC on the specific T cells.
Because ECDI-treated B cells plus macrophages, essentially depleted of T cells,
could induce unresponsiveness in the presence of antigen, an indirect mechanism
involving suppressor T cell induction would seem to be unlikely. Furthermore,
studies by Quill and Schwartz' using planar lipid membranes to induce a similar
nonresponsive state in vitro, have demonstrated that only la molecules and
' Quill, H. and R. H. Schwartz, 1986. Stimulation of normal inducer T cell clones with antigen
presented by purified la molecules in planar lipid membranes:specific induction ofa long-lived state
of proliferative nonresponsiveness. Submitted forpublication.JENKINS AND SCHWARTZ
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antigen are required for this effect. The identical specificity ofTcell unrespon-
siveness induced in vitro and in vivo with that required to stimulate T cell
proliferation in vitro suggests that the same receptor occupancy event occurs in
each instance. These results strongly argue that a functional clonal deletion
mechanism underlies the in vivo unresponsiveness we have observed in our
system. Thus, it should bepossible for the firsttime to dissectoutthe biochemical
basis of T cell unresponsiveness using the in vitro correlate ofan in vivo model
system.
One model for functional clonal deletion involves the blockade of T cell
receptors by antigen/MHC molecules (5, 30). Our results suggest that T cell
receptor blockade or modulation does not account for T cell inactivation since
the in vitro-induced unresponsiveness lasted for at least 8 d in the absence of
tolerogen. Others have demonstrated (41) significant cell surface reexpression
of T cell receptors modulated by mAbs only 48 h after antibody treatment.
Furthermore, Quill and Schwartz' have shown that T cell clones express normal
levels of T cell receptor molecules at times when the cells are completely
unresponsive. However, it is still formally possible that antigen/la molecules
derived from the tolerogen remain associated with the T cell clones for long
periods of time without interfering with the binding ofan anti-V, 3 mAb.
We would propose that the T cells recognize antigen in association with la
molecules on the surface ofECDI-treated APC in a manner similar to that which
occurs on normal APC. However, the ECDI treatment appears to impair an
additional APC signal necessary to induce IL-2 production and T cell prolifera-
tion. This interpretation is consistent with the recent results of Weiss et al. (42),
which demonstrate that certain Tcells require T cell receptor perturbation plus
additional signals to produce IL-2. Our results extend this by suggesting that
incompletesignalingin combination with Tcellreceptor occupancy by antigen/la
molecules results in an unresponsive state. This state appears not to involve
inhibition ofthe IL-2-R pathway, as Tcell clones unable to respondto antigen/la
molecule restimulation responded normally to exogenous IL-2. In addition, this
unresponsive state isinduced in the absence ofT cell proliferation, distinguishing
it from unresponsiveness induced by exposure of T cells to high doses of IL-2
(43). Thus, the model first proposed for B cells by Bretscher and Cohn (44) and
later modified by others (3, 6), in which receptor occupancy in the absence of
other signals results in tolerance induction, could be applied to T cells. If so, T
and B cells would use similar mechanisms of tolerance induction. In this regard,
it should be noted that the in vitro T cell unresponsiveness reported here and
the in vitro B cell unresponsiveness reported by others (45) have similar time
courses of induction.
Preliminary evidence from our laboratory suggests that the T cells are partially
activated after incubation with antigen and ECDI-treated APC and that this
partial activation renders the T cell incapable ofproducing IL-2 for at least 8 d
in vitro. This interpretation differs from previous conclusions on the cellular
basis for antigen-coupled, cell-induced unresponsiveness. It has been proposed
by others (3, 4) that the tolerogenicity of antigen- or hapten-coupled cells is
related to the high antigen density on these cells and the intravenous route of
their administration. Our results suggest that a crucial function of ECDI is not31 6
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only to couple antigen to the splenocytes butalso to inactivate the APC accessory
signal(s) necessary to fully activate T cells.
Lamb et al . (11) have also reported the in vitro induction of unresponsiveness
after incubation of human T cell clones with antigen fragments in the absence
of APC. Since subsequent studies (12) showed that the induction of unrespon-
siveness could be blocked with anti-class 11 MHC antibodies, it is possible that
the class II MHC-positive human T cells were presenting antigen to each other.
Therefore, in both murine and human systems, nonmitogenic antigen presenta-
tion in vitro appears to result in unresponsiveness. A prediction of this type of
model would be that other cells that express surface class II MHC molecules but
do not supportT cell proliferation, e. g., UV-irradiated splenocytes (46), gamma-
irradiated (3,000 rad) resting B cells (47), neonatal splenocytes (48), and possibly
thymic epithelial cells (49), might induce unresponsiveness. Recently published
experiments (50) have shown that even certain nonstimulatory, anti-T cell
receptor mAbs induced a state of unresponsiveness, further supporting the idea
that receptor occupancy under nonmitogenic conditions can result in T cell
inactivation.
In summary, we have shown that nonmitogenic, antigen presentation by ECDI-
treated APC induces inhibition of T cell clones in vitro and in vivo, suggesting
that functional clonal deletion is one mechanism of tolerance induction. Future
experiments will be aimed at identifying the biochemical events resulting in
unresponsiveness, and the nature of the ECDI-sensitive molecule(s) on the APC.
Finally, the possible application of this procedure to inducing specific unrespon-
siveness in ongoing autoimmune disease as well as before organ transplantation
is currently under investigation.
Summary
We investigated the antigen specificity and presentation requirements for
inactivation of T lymphocytes in vitro and in vivo. In vitro studies revealed that
splenocytes treated with the crosslinker 1-ethyl-3-(3-dimethylaminopropyl)-
carbodiimide (ECDI) and soluble antigen fragments failed to stimulate significant
proliferation by normal pigeon cytochrome c-specific T cell clones, suggesting
that the chemical treatment inactivated full antigen presentation function. How-
ever, T cell clones exposed to ECDI-treated splenocytes and antigen in vitro
were rendered unresponsive for at least 8 d to subsequent antigen stimulation
with normal presenting cells. As predicted by the in vitro results, specific T cell
unresponsiveness was also induced in vivo in B10.A mice injected intravenously
with B10.A, but not B10.A(4R), splenocytes coupled with pigeon cytochrome c
via ECDI. The antigen and MHC specificity of the induction of this T cell
unresponsiveness in vitro and in vivo was identical to that required for T cell
activation. These results suggest that nonmitogenic T cell recognition of anti-
gen/MHC on ECDI-modified APCs results in the functional inactivation of T
cell clones .
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